Radiopharmaceutical Manufacturing Unit

Guy's and St Thomas' NHS Foundation Trust is currently in the planning stage for a public procurement process titled "Radiopharmaceutical Manufacturing Unit," which falls within the pharmacy and medical services industry category. The location pertains to London, within the United Kingdom. The procurement involves setting up an advanced GMP-compliant manufacturing unit, focused on radiopharmaceutical products, and is intended to address growing demand in the London area.

A virtual market engagement event is scheduled for 19th September 2025, from 11:30 to 12:30, offering a panel discussion and outlining the procurement approach. Prospective businesses must confirm their participation by 17th September 2025, and further discussions will be available. The Managed Service Agreement (MSA) related to this initiative is anticipated to begin in June 2026, with the contract estimated at £42 million over 12 years, potentially extending to £69 million for an additional 5-year period.

This procurement presents significant opportunities for businesses specialising in pharmacy, radiopharmaceuticals, and medical laboratory services. Companies with expertise in designing, building, and operating complex medical manufacturing facilities would likely benefit from competing for this Managed Service Agreement. As the initiative aims to integrate the new unit with existing NHS pathways and focus on education and clinical research, organizations with a strong commitment to innovation, regulatory compliance, and operational excellence are ideal candidates.

This strategic move to enhance radiopharmaceutical services promises to bolster businesses aiming to expand their market presence within the healthcare sector and collaborate on cutting-edge medical advancements.